https://priyalifescience.com/article/irish-cancer-trial-participation-national-target-2026 Priya Life Science en 2026-11-07T13:00:02+00:00 Irish Cancer Trial Enrolment at 2.9%, Under Half 6% Target https://priyalifescience.com/article/fda-accelerated-approval-rybrevant-faspro-head-neck-cancer-2026 Priya Life Science en 2026-11-07T08:30:01+00:00 FDA Accelerated Approval for J&J's Head and Neck Cancer Drug